Switzerland
# |
Name |
Total Non-Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 5.08 B
|
Dec. 31, 2023 | USD 48.28 | 3.35% |
|
Switzerland |
|
2 |
USD 435.36 M
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
|
3 |
USD 161.18 M
|
Dec. 31, 2023 | USD 45.08 | 2.29% |
|
Switzerland |
|
4 |
USD 145.05 M
|
Dec. 31, 2023 | USD 26.45 | -1.05% |
|
Switzerland |
|
5 |
USD 10.21 M
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
6 |
USD 8.92 M
|
Dec. 31, 2023 | USD 4.99 | 1.08% |
|
Switzerland |
|
7 |
USD 3.08 M
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
The Vaccines company in Switzerland with the highest Total Non-Current Liabilities is Sandoz Group AG (Swiss Stock Exchange: SDZ.SW) at USD 5.08 B.
The Vaccines company in Switzerland with the lowest Total Non-Current Liabilities is MoonLake Immunotherapeutics (NasdaqCM: MLTX) at USD 3.08 M.
The top 10 Vaccines companies in Switzerland by Total Non-Current Liabilities are Sandoz Group AG, ADC Therapeutics SA, Basilea Pharmaceutica AG, PolyPeptide Group AG, AC Immune SA, Molecular Partners AG and MoonLake Immunotherapeutics.
The bottom 10 Vaccines companies in Switzerland by Total Non-Current Liabilities are MoonLake Immunotherapeutics, Molecular Partners AG, AC Immune SA, PolyPeptide Group AG, Basilea Pharmaceutica AG, ADC Therapeutics SA and Sandoz Group AG.